Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

HSV-2 antigen based DC cell and targeting immune cell population, and preparation method and application thereof

An HSV-2, cell technology, applied to other methods of inserting foreign genetic material, cells modified by introducing foreign genetic material, animal cells, etc., can solve the problem of immune cell preparation methods need to be improved, and solve the problem of cytotoxicity , The effect of high preparation efficiency and low cost

Inactive Publication Date: 2015-08-12
SHANGHAI TELEBIO BIOMEDICAL
View PDF1 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] However, the current preparation methods of immune cells for immune cell therapy still need to be improved

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • HSV-2 antigen based DC cell and targeting immune cell population, and preparation method and application thereof
  • HSV-2 antigen based DC cell and targeting immune cell population, and preparation method and application thereof
  • HSV-2 antigen based DC cell and targeting immune cell population, and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0066] 1. Materials and equipment

[0067] 1. Laboratory level: GLP

[0068] 2. Instruments and equipment:

[0069] Negative 80-degree ultra-low temperature refrigerator (Zhongke Meiling, DW-HL388); ordinary refrigerator (Haier, double door, -20°C and 4°C); mold incubator (Shanghai Boxun, MJX-160B-Z); constant temperature water bath ( SSW-420-2S); CO 2 Incubator (HF240); low-speed centrifuge (Shanghai Anting, TDL-40C); inverted biological microscope (Kexin, model: BLD-1); biological safety cabinet (Suzhou purification, double); Rand) 1-10ml; 1 set of micropipettes (Dalong), 4 pieces; programmed cooling box (Thermo); liquid nitrogen tank (Jinfeng, YDS-120-216); PCR instrument; gel electrophoresis imaging system ; Electrophoresis apparatus; Thermostat;

[0070] 3. Cell culture consumables:

[0071] Cell culture bag (Takara company); 75cm 2 Culture bottle, 175cm 2 Culture bottle, 1.8ml cryopreservation tube, 1.5ml EP tube, 50ml centrifuge tube, and 15ml centrifuge tube are...

Embodiment 2

[0133] Embodiment 2: clinical treatment

[0134] The CTL cells prepared in Example 1 were reinfused into the patient, and the reinfusion effect was observed, as follows:

[0135] 20 HSV-2 positive herpes virus patients are divided into 2 groups (10 people in group A and 10 people in group B), wherein, for group A, according to the method in embodiment 1, obtain sufficient amount on the 14th day and the 15th day After CTL cells, reinfuse the patient, and the amount of cells reinfused each time is 1~2*10 9 ; Group B did not reinfuse cells (as a control). One blood collection and two consecutive reinfusions constituted a course of treatment. After 3 courses of treatment, observation was carried out.

[0136] The results showed that there was a significant difference between group A and group B. After reinfusion, all patients in group A felt less tired, increased appetite, less pain, and increased weight. Among them, 6 patients had less symptoms of herpes virus infection; The ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a DC cell and a targeting immune cell population, and a preparation method and application thereof. The preparation method of DC cells includes the steps of: conducting first induced differentiation culture on mononuclear cells in order to obtain immature DC cells; transfecting the immature DC cells by using HSV-2 antigen mRNA, so as to obtain transfected immature DC cells; and conducting second induced differentiation culture on the transfected immature DC cells, so as to obtain mature DC cells, wherein the mononuclear cells are isolated from mononuclear cells of peripheral blood of a sample. The method can prepare DC cells safely and efficiently, has a low cost and high efficiency, and can effectively solve the problem of cytotoxicity. The method can be effectively used for immune cell treatment or stimulation of lymphocytes derived from a same patient to produce a targeting cell population containing a large amount of CTL cells, and then the cell population can be used for virus infection immunotherapy to reach better effect.

Description

technical field [0001] The invention relates to the field of biotechnology, in particular, the invention relates to DC cells, targeted immune cell populations and their preparation methods and applications. Background technique [0002] Malignant tumors are the main type of fatal diseases in humans, and the mortality rate remains high. The latest statistics from the Ministry of Health show that malignant tumors rank first among the top ten causes of death among Chinese residents. In 2010, there were 2.68 million malignant tumor patients in China, and 1.97 million died. At present, there are more than 6 million malignant tumor patients in China. The annual medical expenses for malignant tumor patients account for about 20% of the total health expenses, which is the largest medical burden of the whole society. The current treatment methods are still very limited in achieving the goals of curing, prolonging the survival period of patients with malignant tumors, and improving ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/10C12N15/87C12N5/0783A61K39/245A61K35/17A61P31/22A61P35/00
Inventor 杨光华李财新
Owner SHANGHAI TELEBIO BIOMEDICAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com